GEMMILY Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Gemmily, and what generic alternatives are available?
Gemmily is a drug marketed by Xiromed and is included in one NDA.
The generic ingredient in GEMMILY is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GEMMILY?
- What are the global sales for GEMMILY?
- What is Average Wholesale Price for GEMMILY?
Summary for GEMMILY
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Drug Prices: | Drug price information for GEMMILY |
| DailyMed Link: | GEMMILY at DailyMed |
US Patents and Regulatory Information for GEMMILY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xiromed | GEMMILY | ethinyl estradiol; norethindrone acetate | CAPSULE;ORAL | 213317-001 | Nov 9, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
